• No results found

Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120

N/A
N/A
Protected

Academic year: 2020

Share "Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

References

Related documents

Bough ton et al (2006) conducted a study to determine whether the regular assessment of children’s pain would improve their pain management and pain would improve their

Whereas treatment of Girardenia zeylanica Dcne extract significantly declined the effect of CCl4 induced damage and it was evidenced by the decreased level of total

Aim: To compare the dentinal tubule occluding ability of Pro-Argin based dentifrice and Carbon Dioxide Laser in the treatment of dentinal hypersensitivity.. Materials and Methods:

is to control the precise Gag/Gag-Pol ratio required for parti- cle assembly, then compounds that affect frameshifting should inhibit particle assembly and therefore block

As outlined below, transgenic mouse models of hepatitis infection in the liver indicate that direct lysis mediated by CTL granule exocytosis is a less-favor- able immune

In addition, postchallenge cell-associated virus load was significantly lower in SIV HyIFN -immunized animals than in the group vaccinated.. with SIV

At various times following HSV-1 corneal infection, the eyes of RB6-8C5- treated and control SCID mice were collected, and the infec- tious virus titer in each eye was

The immunoprecipitated material from U-937 and HeLa cells with antibodies to CD46 (13/42), moesin (38/87), and MHC class I (W6/32) was separated by SDS-PAGE and blotted